Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.07 USD | -3.50% | -5.60% | -30.63% |
05/06 | Morgan Stanley Adjusts COMPASS Pathways Price Target to $23 From $30, Maintains Overweight Rating | MT |
04/06 | FDA panel to review psychedelic drug MDMA for first time | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.63% | 415M | |
+38.36% | 52.73B | |
+36.73% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |
- Stock Market
- Equities
- CMPS Stock
- News COMPASS Pathways plc
- Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing